House bill · 89R

HB 2845

Relating to the designation of controlled substance overdose for purposes of the death certificate.

Did not pass

Progress

33 days from first to latest action, across 3 recorded actions.

Filed
Feb 14
Referred to committee
Mar 19
Heard in committee
Stopped here
Reported from committee
Passed first chamber
Passed second chamber
Sent to governor
Became law

Filled marks are milestones (committee report, floor passage, governor action). Larger marks hold more same-day actions.

Full history

Every action recorded by Texas Legislature Online.

Referred to Public Health Public Health
Mar 19, 2025 · House
Read first time
Mar 19, 2025 · House
Filed
Feb 14, 2025 · House

Authors

Matt ShaheenR

In committee

Public Health
House
Referred Mar 19, 2025 · never reported

Topics

Crimes: Drugs Health: General

Bill text

IntroducedHTML PDF

Bills on similar topics

Other legislation this session sharing the most index topics.

Bill	Author	Progress	Status	Last action
SB 3Relating to the regulation of products derived from hemp, including consumable hemp products and the hemp-derived cannabinoids contained in those products; requiring occupational licenses and permits; imposing fees; creating criminal offenses; authorizing an administrative penalty.	Charles PerryR	Sent to governor	Vetoed	Jun 22, 2025Vetoed by the Governor
SB 1868Relating to adding certain substances to the Texas Controlled Substances Act and regulating kratom and kratom products; increasing civil penalties; creating criminal offenses; increasing a criminal penalty.	Charles PerryR	Passed first chamber	Did not pass	Apr 28, 2025Referred to Public Health
HB 1837Relating to the enforcement and prevention of offenses involving the manufacture or delivery of controlled substances listed in Penalty Group 1 or 1-B, law enforcement officer safety in handling those substances, and the manufacture and proper use of opioid antagonists.	Ryan GuillenR	Passed first chamber	Did not pass	May 13, 2025Referred to Criminal Justice
SB 1869Relating to the procedures for modifying the schedules of controlled substances.	Charles PerryR	Passed first chamber	Did not pass	Apr 22, 2025Referred to Public Health
HB 3078Relating to manufacturer fees for operation of a real-time electronic logging system to track over-the-counter sales of ephedrine, pseudoephedrine, or norpseudoephedrine; imposing a fee; authorizing an administrative penalty.	Drew DarbyR	Reported from committee	Did not pass	Apr 25, 2025Committee report sent to Calendars
HB 3717Relating to the establishment of a grant program to fund the United States Food and Drug Administration's drug development trials with ibogaine for the purpose of securing the administration's approval as a medication for treatment of opioid use disorder, co-occurring substance use disorder, and any other neurological or mental health conditions for which ibogaine demonstrates efficacy.	Cody HarrisR	Reported from committee	Did not pass	May 12, 2025Laid on the table subject to call